- $20.83bn
- $22.63bn
- $5.37bn
- 93
- 25
- 95
- 82
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,947 | 3,683 | 4,194 | 4,948 | 5,373 |
Cost of Revenue | |||||
Gross Profit | 1,192 | 1,102 | 1,154 | 1,482 | 1,893 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3,398 | 3,196 | 3,686 | 4,246 | 4,334 |
Operating Profit | 548 | 487 | 509 | 702 | 1,039 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 469 | 425 | 459 | 657 | 983 |
Provision for Income Taxes | |||||
Net Income After Taxes | 368 | 335 | 371 | 517 | 766 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 401 | 351 | 400 | 546 | 760 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 400 | 350 | 398 | 545 | 758 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 6.68 | 6.44 | 7.06 | 9.68 | 14.1 |
Dividends per Share |